Literature DB >> 16462753

Prions and their lethal journey to the brain.

Neil A Mabbott1, G Gordon MacPherson.   

Abstract

Prion diseases are neurodegenerative conditions that cause extensive damage to nerve cells within the brain and can be fatal. Some prion disease agents accumulate first in lymphoid tissues, as they make their journey from the site of infection, such as the gut, to the brain. Studies in mouse models have shown that this accumulation is obligatory for the efficient delivery of prions to the brain. Indeed, if the accumulation of prions in lymphoid tissues is blocked, disease susceptibility is reduced. Therefore, the identification of the cells and molecules that are involved in the delivery of prions to the brain might identify targets for therapeutic intervention. This review describes the current understanding of the mechanisms involved in the delivery of prions to the brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16462753     DOI: 10.1038/nrmicro1346

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  66 in total

1.  Interaction between dendritic cells and nerve fibres in lymphoid organs after oral scrapie exposure.

Authors:  Gauthier Dorban; Valérie Defaweux; Caroline Demonceau; Sylvain Flandroy; Pierre-Bernard Van Lerberghe; Nandini Falisse-Poirrier; Joëlle Piret; Ernst Heinen; Nadine Antoine
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

2.  Oral scrapie infection modifies the homeostasis of Peyer's patches' dendritic cells.

Authors:  Gauthier Dorban; Valérie Defaweux; Etienne Levavasseur; Caroline Demonceau; Olivier Thellin; Sylvain Flandroy; Joëlle Piret; Nandini Falisse; Ernst Heinen; Nadine Antoine
Journal:  Histochem Cell Biol       Date:  2007-07-11       Impact factor: 4.304

3.  Alteration of B-cell subsets enhances neuroinvasion in mouse scrapie infection.

Authors:  Christine von Poser-Klein; Eckhard Flechsig; Tanja Hoffmann; Petra Schwarz; Harry Harms; Raymond Bujdoso; Adriano Aguzzi; Michael A Klein
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

4.  Prions hijack tunnelling nanotubes for intercellular spread.

Authors:  Karine Gousset; Edwin Schiff; Christelle Langevin; Zrinka Marijanovic; Anna Caputo; Duncan T Browman; Nicolas Chenouard; Fabrice de Chaumont; Angelo Martino; Jost Enninga; Jean-Christophe Olivo-Marin; Daniela Männel; Chiara Zurzolo
Journal:  Nat Cell Biol       Date:  2009-02-08       Impact factor: 28.824

5.  Characterization of newly established bovine intestinal epithelial cell line.

Authors:  Kohtaro Miyazawa; Tetsuya Hondo; Takashi Kanaya; Sachi Tanaka; Ikuro Takakura; Wataru Itani; Michael T Rose; Haruki Kitazawa; Takahiro Yamaguchi; Hisashi Aso
Journal:  Histochem Cell Biol       Date:  2009-10-15       Impact factor: 4.304

6.  Expression of mesenchyme-specific gene signatures by follicular dendritic cells: insights from the meta-analysis of microarray data from multiple mouse cell populations.

Authors:  Neil A Mabbott; J Kenneth Baillie; Atsushi Kobayashi; David S Donaldson; Hitoshi Ohmori; Sun-Ok Yoon; Arnold S Freedman; Tom C Freeman; Kim M Summers
Journal:  Immunology       Date:  2011-06-03       Impact factor: 7.397

Review 7.  Histochemistry and cell biology: the annual review 2010.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2011-01-29       Impact factor: 4.304

Review 8.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 9.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

10.  GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells.

Authors:  Jonathan O Speare; Danielle K Offerdahl; Aaron Hasenkrug; Aaron B Carmody; Gerald S Baron
Journal:  EMBO J       Date:  2010-01-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.